Just diagnosed with Primary systemic amyloidosis?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Primary systemic amyloidosis, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Primary systemic amyloidosis hub →Overview
Primary systemic amyloidosis is a rare condition. Also known as Systemic AL amyloidosis. Tomeko brings together the specialists, research, clinical trials, treatments and community for Primary systemic amyloidosis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:314701 · OMIM 254500 · ICD-10 E85.0, E85.1, E85.2 · GARD 0017431
Find care for Primary systemic amyloidosis
Authoritative references for Primary systemic amyloidosis
Research & market landscape for Primary systemic amyloidosis
Following Primary systemic amyloidosis for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Primary systemic amyloidosis — the real-world landscape behind the condition, in one place.
- Latest Primary systemic amyloidosis research on PubMed ↗
- Recruiting Primary systemic amyloidosis trials on ClinicalTrials.gov ↗
- Explore the Primary systemic amyloidosis research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Primary systemic amyloidosis and every rare condition. See how Tomeko works with industry →
Common questions
What is Primary systemic amyloidosis?
Primary systemic amyloidosis is a rare condition. Also known as Systemic AL amyloidosis. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Primary systemic amyloidosis together in one place.
What are the symptoms of Primary systemic amyloidosis?
Symptoms of Primary systemic amyloidosis vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Primary systemic amyloidosis.
How is Primary systemic amyloidosis treated?
Treatment for Primary systemic amyloidosis depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Primary systemic amyloidosis, and review current options with them.
What causes Primary systemic amyloidosis — is it genetic?
The cause and inheritance of Primary systemic amyloidosis are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Primary systemic amyloidosis can explain what it means for you and your family.
I was just diagnosed with Primary systemic amyloidosis — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Primary systemic amyloidosis, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Primary systemic amyloidosis?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Primary systemic amyloidosis, filtered to your area.
Are there clinical trials for Primary systemic amyloidosis?
Tomeko shows live, recruiting studies for Primary systemic amyloidosis from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3